On Demand Webinars

Zika Virus: Diagnostic Testing and Front-Line Management 
This webinar is jointly sponsored by PASCV and the Association for Molecular Pathology (AMP).

Webinar Access 

Click here to access the webinar. 

P.A.C.E. ®
Click here to receive P.A.C.E. ® credit. 


1.0 Contact Hours

PASCV is approved as as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. 

Program Information

Kevin Alby, Ph.D.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Benjamin Pinksy, M.D., Ph.D. 
Stanford University Medical Center, Palo Alto, CA

Zika virus (ZIKV) is an Aedes mosquito-borne flavivirus that emerged in Brazil in 2015 and then rapidly spread throughout the tropical and subtropical Americas. Based on clinical criteria alone, ZIKV cannot be reliably distinguished from infections with other pathogens that cause an undifferentiated systemic febrile illness, including infections with two common arboviruses, dengue virus and chikungunya virus. This presentation details the methods that are available to diagnose ZIKV infection.


Cecilia Perret, M.D. 

Pontifica Universidad Catolica de Chile, Santiago, Chile 

This presentation will review epidemiology of Zika outbreak in Latin America, some clinical aspects, evidence of zika infection and its complications (congenital disease and Guillain Barre Syndrome), local information of our series of travelers infected with Zika including a pregnant women and sexual transmitted infection.

Upon completion of this webinar, the participant should be able to:

- Discuss the advantages and disadvantages of Zika virus antibody testing;

- Discuss the advantages and disadvantages of Zika virus RNA testing;

- Explore the utility of multiplex testing for co-circulating arboviruses;

- Understand Zika epidemiology in Latin America;

- Discuss clinical aspects of Zika infection; and 

- Discuss complications of Zika infection in recent studies.


Level: Basic/Intermediate


NAATs for Rapid Detection of Influenza Virus: Time for a Paradigm Shift?


Webinar Access 

Click here to access the webinar. Recording is available to members only.


Program Information


Diane S. Leland, Ph.D.
Indiana University Health Pathology Laboratory, Indianapolis, IN


Richard L. Hodinka, Ph.D.
University of South Carolina School of Medicine and Greenville Health System, Greenville, SC


Influenza is a contagious respiratory illness that can be quite serious and result in significant hospitalization and death, particularly in the very young, the elderly, and individuals with underlying comorbid conditions.  Rapid and accurate detection of influenza disease can play an important role in clinical care and management, but detection of influenza viruses using traditional methods can be challenging.  In this program, we will explore the latest advances in molecular technology for the rapid detection of influenza viruses, discuss some of the issues surrounding these methods, and describe the potential impact of these newer tests on patient care and health-related outcomes.


Upon completion of this webinar, the participant should be able to: 

· Discuss the newest molecular technologies available for the rapid detection of influenza viruses;

· Explain the advantages and disadvantages of rapid nucleic acid amplification tests for influenza virus detection; and

· Discuss how these newer molecular technologies may change the clinical and diagnostic paradigm in the care and management of individuals with influenza. 


 Level: Intermediate

Association Management Software Powered by YourMembership  ::  Legal